Journal article

Usefulness of Transient and Persistent No Reflow to Predict Adverse Clinical Outcomes Following Percutaneous Coronary Intervention

William Chan, Dion Stub, David J Clark, Andrew E Ajani, Nick Andrianopoulos, Angela L Brennan, Gishel New, Alexander Black, James A Shaw, Christopher M Reid, Anthony M Dart, Stephen J Duffy

AMERICAN JOURNAL OF CARDIOLOGY | EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC | Published : 2012

Grants

Funding Acknowledgements

The Melbourne Interventional Group acknowledges unrestricted educational grant funding from Abbot Vascular, AstraZeneca, Biotronik, Boston-Scientific, Bristol-Myers Squibb, CSL, Johnson and Johnson, Medtronic, Pfizer, Schering-Plough, Sanofi-Aventis, and Servier.Dr. Chan is supported by scholarships from the National Health and Medical Research Council (NHMRC) of Australia, Canberra, ACT, Australia and GlaxoSmithKline. Dr. Duffy's work is supported by an NHMRC of Australia Program Grant. The work of Dr. Reid, Ms. Brennan, and Dr. Andrianopoulos is supported by an NHMRC of Australia Program Grant.